The structure of the follistatin:activin complex reveals antagonism of both type I and type II receptor binding
about
Epigenetic mechanism underlying the development of polycystic ovary syndrome (PCOS)-like phenotypes in prenatally androgenized rhesus monkeysMembers of the DAN family are BMP antagonists that form highly stable noncovalent dimersDifferential antagonism of activin, myostatin and growth and differentiation factor 11 by wild-type and mutant follistatinActivins and activin antagonists in hepatocellular carcinomaFoxL2 and Smad3 coordinately regulate follistatin gene transcriptionDifferential regulation of follicle stimulating hormone by activin A and TGFB1 in murine gonadotropes.Physiologic Course of Female Reproductive Function: A Molecular Look into the Prologue of LifeRegulation of the ovarian reserve by members of the transforming growth factor beta familyThe DAN family: modulators of TGF-β signaling and beyondPhylogenomic analyses reveal the evolutionary origin of the inhibin alpha-subunit, a unique TGFbeta superfamily antagonistStructural and biophysical coupling of heparin and activin binding to follistatin isoform functionsThe Structure of FSTL3{middle dot}Activin A Complex: DIFFERENTIAL BINDING OF N-TERMINAL DOMAINS INFLUENCES FOLLISTATIN-TYPE ANTAGONIST SPECIFICITYSolution Structure of Factor I-like Modules from Complement C7 Reveals a Pair of Follistatin Domains in Compact Pseudosymmetric ArrangementThe structure of myostatin:follistatin 288: insights into receptor utilization and heparin bindingStructure of Myostatin·Follistatin-like 3Structure of Protein Related to Dan and Cerberus: Insights into the Mechanism of Bone Morphogenetic Protein AntagonismThe clip-segment of the von Willebrand domain 1 of the BMP modulator protein Crossveinless 2 is preformedIntertwining of Activin A and TGFβ Signaling: Dual Roles in Cancer Progression and Cancer Cell InvasionA Smad-binding element in intron 1 participates in activin-dependent regulation of the follistatin geneStructure of neuroblastoma suppressor of tumorigenicity 1 (NBL1): insights for the functional variability across bone morphogenetic protein (BMP) antagonists.Overexpression of follistatin in the mouse epididymis disrupts fluid resorption and sperm transit in testicular excurrent ductsStructural basis for potency differences between GDF8 and GDF11.Activator protein-1 and smad proteins synergistically regulate human follicle-stimulating hormone beta-promoter activityMolecular profiling of conjunctival epithelial side-population stem cells: atypical cell surface markers and sources of a slow-cycling phenotypeInsulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.Differential effects of follistatin on nonhuman primate oocyte maturation and pre-implantation embryo development in vitro.Minireview: Activin Signaling in Gonadotropes: What Does the FOX say… to the SMAD?Activin signaling is an essential component of the TGF-β induced pro-metastatic phenotype in colorectal cancer.Spemann's organizer and self-regulation in amphibian embryos.Inhibin at 90: from discovery to clinical application, a historical reviewGenome-wide host responses against infectious laryngotracheitis virus vaccine infection in chicken embryo lung cells.Activins and follistatins: Emerging roles in liver physiology and cancerFollistatin is a novel biomarker for lung adenocarcinoma in humans.TGFβ signaling promotes juvenile granulosa cell tumorigenesis by suppressing apoptosis.Biochemistry and Biology of GDF11 and Myostatin: Similarities, Differences, and Questions for Future InvestigationRole of activins in embryo implantation and diagnosis of ectopic pregnancy: a review.Extracellular Regulation of Myostatin: A Molecular Rheostat for Muscle Mass.Eye morphogenesis driven by epithelial flow into the optic cup facilitated by modulation of bone morphogenetic protein.Follistatin improves skeletal muscle healing after injury and disease through an interaction with muscle regeneration, angiogenesis, and fibrosis.Alternative binding modes identified for growth and differentiation factor-associated serum protein (GASP) family antagonism of myostatin.
P2860
Q21134965-9DB24ED6-1C76-4733-BDAF-90C0D73C0A60Q24300782-30C6D478-92E7-4BC5-A657-DD5AB7CEC097Q24644694-D08F1C25-65F0-45AF-BB6B-8A3232EDDED1Q24646221-47B7E722-EBD4-4ECD-92CB-FD40D53EBB75Q24655444-6AA3E4AF-E72B-4E7C-AC15-B3D91E5CED22Q25255835-52DE369E-8100-4BE6-A632-1784416A17AFQ26772258-50DC4F06-2524-4CF6-808C-22CFEF203C32Q26996828-1093A819-8810-48FF-A640-DFE589C6A17EQ27025762-EB0D533A-9C95-48A3-90D3-4CE5B20EC766Q27333889-A360FA37-D347-48CC-B158-8A72C9FD6FF6Q27644355-18014621-F9B9-4ED6-BF60-8D91553975F5Q27651961-CD1CC63C-04E5-477C-ADD1-8B0AEEFD7D04Q27655389-3C9856B0-4608-48AB-8BCC-D90AF7483D9BQ27656789-E3D619E1-18E5-45E6-8860-AFC1B14DD1EEQ27675374-BFCF75F4-A048-4BD3-BD01-8E04D3C897F4Q27679073-1A01861F-21AC-4C50-B7FE-1DEBC332B0B3Q27686823-45F37E31-4185-40AD-B96C-A0AB228B02A1Q28082707-813CA65F-B3EE-42C4-9EE0-8A9AB58A3029Q28264153-F682C436-9442-4A93-9606-E7B114BA7D68Q30090227-A5A6E2BD-2248-4341-8B7A-0F46BA875F78Q30417842-0AAD4FFE-B64B-4B27-BE26-BCC918CB0217Q31813087-5972FC1F-9F5F-4508-B310-E7DE217D7D39Q33354872-FE0481E7-7DC9-45B5-8974-E8AD3CCEADEDQ33422792-DA0DDEA8-D6CD-4B6F-8AF2-4847D9159039Q33569169-2DF92AF8-B469-42D6-A4ED-EAEFB9D6FFB6Q33573789-15D906B4-3FF2-43A0-B443-F12BF8A75DACQ33631605-F95F5019-B249-4D01-A11D-BA2C4C369CFAQ33912255-B8E4126E-1566-4B6F-91B8-F9E21A6A72EBQ33993579-270E784D-705D-47D7-A09B-7ACFA121A834Q34204531-0BD75117-F0F5-454F-9EE9-2AD9DB6F3828Q34244274-0DC6C6CA-5ADF-435B-90F1-E767445D3A9DQ34391497-F5481FDE-648D-48F5-91F7-FAEFEFF60286Q34408498-2BF379EF-9AB3-4F7D-A66F-475D93546054Q34422499-4D850744-0F74-4291-80C5-F46B7F457DA7Q34520504-059E3148-75EA-4747-84B0-64611FFBA110Q34623539-54EC0142-A00E-4E1B-A419-591FCB1FF40CQ34694932-3A8A3B41-AAFF-4E75-99D1-6B8F73B98F51Q35111530-320BB475-E406-4EB3-B1D4-47927057E65DQ35167976-87F6A9AB-5DDB-476C-BF0B-9E0765CB365FQ35199362-F2A26FE9-072A-4B28-AD93-F5D9EBF80182
P2860
The structure of the follistatin:activin complex reveals antagonism of both type I and type II receptor binding
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The structure of the follistat ...... I and type II receptor binding
@ast
The structure of the follistat ...... I and type II receptor binding
@en
The structure of the follistat ...... I and type II receptor binding
@en-gb
The structure of the follistat ...... I and type II receptor binding
@nl
type
label
The structure of the follistat ...... I and type II receptor binding
@ast
The structure of the follistat ...... I and type II receptor binding
@en
The structure of the follistat ...... I and type II receptor binding
@en-gb
The structure of the follistat ...... I and type II receptor binding
@nl
prefLabel
The structure of the follistat ...... I and type II receptor binding
@ast
The structure of the follistat ...... I and type II receptor binding
@en
The structure of the follistat ...... I and type II receptor binding
@en-gb
The structure of the follistat ...... I and type II receptor binding
@nl
P2093
P3181
P1433
P1476
The structure of the follistat ...... I and type II receptor binding
@en
P2093
Robert W Cook
Theodore S Jardetzky
Thomas F Lerch
P304
P3181
P356
10.1016/J.DEVCEL.2005.09.008
P407
P577
2005-10-01T00:00:00Z